• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

cancer

  • New AI tool predicts colon cancer survival, treatment response
    April 19, 2023

    New AI tool predicts colon cancer survival, treatment response

    bricemarsters
  • Hallmarks to improving pancreatic cancer therapy identified by UC Irvine researchers
    April 18, 2023

    Hallmarks to improving pancreatic cancer therapy identified by UC Irvine researchers

    bricemarsters
  • Implantable device shrinks pancreatic tumors
    April 18, 2023

    Implantable device shrinks pancreatic tumors

    bricemarsters
  • New therapy harnesses patients’ blood cells to fight tumors
    April 15, 2023

    New therapy harnesses patients’ blood cells to fight tumors

    bricemarsters
  • Identifying cancer genes’ multiple personalities
    April 13, 2023

    Identifying cancer genes’ multiple personalities

    bricemarsters
  • Two Ludwig cancer research studies reveal essential role of neutrophils in immunotherapy
    April 5, 2023

    Two Ludwig cancer research studies reveal essential role of neutrophils in immunotherapy

    bricemarsters
  • Research autopsies reveal how incurable skin cancer resists treatment
    April 4, 2023

    Research autopsies reveal how incurable skin cancer resists treatment

    bricemarsters
  • Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past.
    April 3, 2023

    Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past.

    scientificinquirer
  • COVID vaccine induces robust T cell responses in blood cancer patients
    April 3, 2023

    COVID vaccine induces robust T cell responses in blood cancer patients

    bricemarsters
  • REBEL REBEL TEMPLATE: William Bradley Coley and Coley’s Toxins was over a hundred  years ahead of its time.
    March 30, 2023

    REBEL REBEL TEMPLATE: William Bradley Coley and Coley’s Toxins was over a hundred years ahead of its time.

    scientificinquirer
Previous Page
1 … 21 22 23 24 25 … 53
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
 

Loading Comments...